Search Ontology:
ChEBI
dihydroouabain
- Term ID
- CHEBI:131146
- Synonyms
-
- (1beta,3beta,5beta,11alpha,20xi)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycardanolide
- (20xi)-3beta-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1beta,5,11alpha,14,19-pentahydroxy-5beta-cardanolide
- 3beta-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-1beta,5,11alpha,14,19-pentahydroxy-5beta,20xi-cardanolide
- dihydro-g-strophanthin
- dihydroouabain
- Definition
- A cardenolide glycoside that is ouabain in which the double bond in the lactone ring has been reduced to a single bond. It is a cardiac glycoside and a derivative of ouabain which is used as a sodium pump antagonist and exhibits ionotropic effects.
- References
-
- CAS:1183-35-3
- HMDB:HMDB0251322
- LINCS:LSM-42697
- PMID:10564763
- PMID:1178065
- PMID:1192564
- PMID:1239002
- PMID:12399817
- PMID:12954807
- PMID:1311424
- PMID:19778013
- PMID:2442703
- PMID:2541941
- PMID:2851817
- PMID:29981919
- PMID:32311597
- PMID:6290892
- PMID:6326779
- PMID:6571229
- PMID:677969
- PMID:7498266
- PMID:7854342
- PMID:8387052
- PMID:8411196
- PMID:978481
- Reaxys:71786
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_functional_parent
-
- has_role
-
Phenotype
Phenotype resulting from dihydroouabain
Phenotype where environments contain dihydroouabain
Phenotype modified by environments containing dihydroouabain
Human Disease Model